Blood Pressure Management and Evolution of Thrombolysis-associated Intracerebral Hemorrhage in Acute Ischemic Stroke

Background There is limited knowledge on the radiographic features of thrombolysis-induced hemorrhage. The factors that influence early hematoma expansion have not been elucidated. Methods Patients presenting with a symptomatic intracerebral hemorrhage (ICH) as a result of intravenous (IV) thromboly...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of stroke and cerebrovascular diseases 2012-11, Vol.21 (8), p.852-859
Hauptverfasser: Mokin, Maxim, MD, PhD, Kass-Hout, Tareq, MD, Kass-Hout, Omar, MD, Zivadinov, Robert, MD, PhD, Mehta, Bijal, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 859
container_issue 8
container_start_page 852
container_title Journal of stroke and cerebrovascular diseases
container_volume 21
creator Mokin, Maxim, MD, PhD
Kass-Hout, Tareq, MD
Kass-Hout, Omar, MD
Zivadinov, Robert, MD, PhD
Mehta, Bijal, MD
description Background There is limited knowledge on the radiographic features of thrombolysis-induced hemorrhage. The factors that influence early hematoma expansion have not been elucidated. Methods Patients presenting with a symptomatic intracerebral hemorrhage (ICH) as a result of intravenous (IV) thrombolysis with tissue plasminogen activator (tPA) for acute ischemic stroke and had noncontrast computed tomographic (CT) scans of the head were included in this retrospective study. Calculation of hematoma volumes was obtained. Analysis of covariance was used to evaluate for the effect of baseline blood pressure (BP) on initial hematoma volume and further growth. Results Of 267 patients who were treated with intravenous tPA for acute ischemic stroke at our facility between January 1, 2005 and December 31, 2009, 17 patients developed symptomatic ICH and were included in the final analysis. There was a positive correlation between baseline level of systolic BP after thrombolysis and initial hematoma volume (r = 0.46; P = .03) but not for the diastolic BP (r = 0.07; P = .40). There was a significant increase in mean hematoma volume expansion when comparing results between the first and second CT scans (median 9 hours, 22 minutes; 14.9 ± 19.6 cm3 to 26.0 ± 26.7 cm3 ; P = .04). There was also a negative association between the reduction of systolic BP and hematoma growth (r = -0.67; P = .02), but no correlation with change in diastolic BP (r = -0.22; P = .28). Conclusions Once diagnosed, thrombolysis-induced symptomatic ICH undergoes significant early expansion in size. Systolic BP may play a role in hematoma expansion.
doi_str_mv 10.1016/j.jstrokecerebrovasdis.2011.05.006
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1139617955</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1052305711001133</els_id><sourcerecordid>1139617955</sourcerecordid><originalsourceid>FETCH-LOGICAL-c525t-c99a6274eff98f8732d4e921b0d6d5b3efe4abed85f6c90ffabb2f5cc344ff723</originalsourceid><addsrcrecordid>eNqVkk1v1DAQhiMEoqXwF5CPCCnBH3E-Lkht1dKVFoHUcrYce8w6TeziSVbaf0_SbTkgLpw8h1fPjB-9WfaR0YJRVn3qix6nFO_BQIIuxb1G67HglLGCyoLS6kV2yqTgeSMZe7nMVPJcUFmfZG8Qe7oEZSNfZyec1VQ0dXOaTRdDjJZ8T4A4JyBfddA_YYQwER0sudrHYZ58DCQ6crdLcezicECPuUaMxusJLNmEKenjTXogNzDGlHYLhfhAzs08Admg2cHoDbl9vP9t9srpAeHd03uW_bi-uru8ybffvmwuz7e5kVxOuWlbXfG6BOfaxjW14LaElrOO2srKToCDUndgG-kq01LndNdxJ40RZelczcVZ9uHIfUjx1ww4qdGjgWHQAeKMijHRVqxupVyiF8eoSRExgVMPyY86HRSjarWvevUv-2q1r6hUi_0F8v5p39yNYP8gnnUvge0xAMuv9x6SQuMhGLA-gZmUjf7_9n3-C2cGH7zRwz0cAPs4p7D4VUwhV1Tdrn1Y68DYWgUhxG_V4LzY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1139617955</pqid></control><display><type>article</type><title>Blood Pressure Management and Evolution of Thrombolysis-associated Intracerebral Hemorrhage in Acute Ischemic Stroke</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Mokin, Maxim, MD, PhD ; Kass-Hout, Tareq, MD ; Kass-Hout, Omar, MD ; Zivadinov, Robert, MD, PhD ; Mehta, Bijal, MD</creator><creatorcontrib>Mokin, Maxim, MD, PhD ; Kass-Hout, Tareq, MD ; Kass-Hout, Omar, MD ; Zivadinov, Robert, MD, PhD ; Mehta, Bijal, MD</creatorcontrib><description>Background There is limited knowledge on the radiographic features of thrombolysis-induced hemorrhage. The factors that influence early hematoma expansion have not been elucidated. Methods Patients presenting with a symptomatic intracerebral hemorrhage (ICH) as a result of intravenous (IV) thrombolysis with tissue plasminogen activator (tPA) for acute ischemic stroke and had noncontrast computed tomographic (CT) scans of the head were included in this retrospective study. Calculation of hematoma volumes was obtained. Analysis of covariance was used to evaluate for the effect of baseline blood pressure (BP) on initial hematoma volume and further growth. Results Of 267 patients who were treated with intravenous tPA for acute ischemic stroke at our facility between January 1, 2005 and December 31, 2009, 17 patients developed symptomatic ICH and were included in the final analysis. There was a positive correlation between baseline level of systolic BP after thrombolysis and initial hematoma volume (r = 0.46; P = .03) but not for the diastolic BP (r = 0.07; P = .40). There was a significant increase in mean hematoma volume expansion when comparing results between the first and second CT scans (median 9 hours, 22 minutes; 14.9 ± 19.6 cm3 to 26.0 ± 26.7 cm3 ; P = .04). There was also a negative association between the reduction of systolic BP and hematoma growth (r = -0.67; P = .02), but no correlation with change in diastolic BP (r = -0.22; P = .28). Conclusions Once diagnosed, thrombolysis-induced symptomatic ICH undergoes significant early expansion in size. Systolic BP may play a role in hematoma expansion.</description><identifier>ISSN: 1052-3057</identifier><identifier>EISSN: 1532-8511</identifier><identifier>DOI: 10.1016/j.jstrokecerebrovasdis.2011.05.006</identifier><identifier>PMID: 21703878</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Acute stroke ; Aged ; Aged, 80 and over ; Antihypertensive Agents - therapeutic use ; blood pressure ; Blood Pressure - drug effects ; Brain Ischemia - drug therapy ; Cardiovascular ; Cerebral Hemorrhage - chemically induced ; Cerebral Hemorrhage - diagnostic imaging ; Cerebral Hemorrhage - physiopathology ; Disease Progression ; Female ; Fibrinolytic Agents - administration &amp; dosage ; Fibrinolytic Agents - adverse effects ; Hematoma - chemically induced ; Hematoma - diagnostic imaging ; Hematoma - physiopathology ; Humans ; intracerebral hemorrhage ; Male ; Middle Aged ; Neurology ; Retrospective Studies ; Stroke - drug therapy ; Systole ; thrombolysis ; Thrombolytic Therapy - adverse effects ; Time Factors ; tissue plasminogen activator ; Tissue Plasminogen Activator - administration &amp; dosage ; Tissue Plasminogen Activator - adverse effects ; Tomography, X-Ray Computed</subject><ispartof>Journal of stroke and cerebrovascular diseases, 2012-11, Vol.21 (8), p.852-859</ispartof><rights>National Stroke Association</rights><rights>2012 National Stroke Association</rights><rights>Copyright © 2012 National Stroke Association. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c525t-c99a6274eff98f8732d4e921b0d6d5b3efe4abed85f6c90ffabb2f5cc344ff723</citedby><cites>FETCH-LOGICAL-c525t-c99a6274eff98f8732d4e921b0d6d5b3efe4abed85f6c90ffabb2f5cc344ff723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1052305711001133$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21703878$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mokin, Maxim, MD, PhD</creatorcontrib><creatorcontrib>Kass-Hout, Tareq, MD</creatorcontrib><creatorcontrib>Kass-Hout, Omar, MD</creatorcontrib><creatorcontrib>Zivadinov, Robert, MD, PhD</creatorcontrib><creatorcontrib>Mehta, Bijal, MD</creatorcontrib><title>Blood Pressure Management and Evolution of Thrombolysis-associated Intracerebral Hemorrhage in Acute Ischemic Stroke</title><title>Journal of stroke and cerebrovascular diseases</title><addtitle>J Stroke Cerebrovasc Dis</addtitle><description>Background There is limited knowledge on the radiographic features of thrombolysis-induced hemorrhage. The factors that influence early hematoma expansion have not been elucidated. Methods Patients presenting with a symptomatic intracerebral hemorrhage (ICH) as a result of intravenous (IV) thrombolysis with tissue plasminogen activator (tPA) for acute ischemic stroke and had noncontrast computed tomographic (CT) scans of the head were included in this retrospective study. Calculation of hematoma volumes was obtained. Analysis of covariance was used to evaluate for the effect of baseline blood pressure (BP) on initial hematoma volume and further growth. Results Of 267 patients who were treated with intravenous tPA for acute ischemic stroke at our facility between January 1, 2005 and December 31, 2009, 17 patients developed symptomatic ICH and were included in the final analysis. There was a positive correlation between baseline level of systolic BP after thrombolysis and initial hematoma volume (r = 0.46; P = .03) but not for the diastolic BP (r = 0.07; P = .40). There was a significant increase in mean hematoma volume expansion when comparing results between the first and second CT scans (median 9 hours, 22 minutes; 14.9 ± 19.6 cm3 to 26.0 ± 26.7 cm3 ; P = .04). There was also a negative association between the reduction of systolic BP and hematoma growth (r = -0.67; P = .02), but no correlation with change in diastolic BP (r = -0.22; P = .28). Conclusions Once diagnosed, thrombolysis-induced symptomatic ICH undergoes significant early expansion in size. Systolic BP may play a role in hematoma expansion.</description><subject>Acute stroke</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>blood pressure</subject><subject>Blood Pressure - drug effects</subject><subject>Brain Ischemia - drug therapy</subject><subject>Cardiovascular</subject><subject>Cerebral Hemorrhage - chemically induced</subject><subject>Cerebral Hemorrhage - diagnostic imaging</subject><subject>Cerebral Hemorrhage - physiopathology</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Fibrinolytic Agents - administration &amp; dosage</subject><subject>Fibrinolytic Agents - adverse effects</subject><subject>Hematoma - chemically induced</subject><subject>Hematoma - diagnostic imaging</subject><subject>Hematoma - physiopathology</subject><subject>Humans</subject><subject>intracerebral hemorrhage</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neurology</subject><subject>Retrospective Studies</subject><subject>Stroke - drug therapy</subject><subject>Systole</subject><subject>thrombolysis</subject><subject>Thrombolytic Therapy - adverse effects</subject><subject>Time Factors</subject><subject>tissue plasminogen activator</subject><subject>Tissue Plasminogen Activator - administration &amp; dosage</subject><subject>Tissue Plasminogen Activator - adverse effects</subject><subject>Tomography, X-Ray Computed</subject><issn>1052-3057</issn><issn>1532-8511</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkk1v1DAQhiMEoqXwF5CPCCnBH3E-Lkht1dKVFoHUcrYce8w6TeziSVbaf0_SbTkgLpw8h1fPjB-9WfaR0YJRVn3qix6nFO_BQIIuxb1G67HglLGCyoLS6kV2yqTgeSMZe7nMVPJcUFmfZG8Qe7oEZSNfZyec1VQ0dXOaTRdDjJZ8T4A4JyBfddA_YYQwER0sudrHYZ58DCQ6crdLcezicECPuUaMxusJLNmEKenjTXogNzDGlHYLhfhAzs08Admg2cHoDbl9vP9t9srpAeHd03uW_bi-uru8ybffvmwuz7e5kVxOuWlbXfG6BOfaxjW14LaElrOO2srKToCDUndgG-kq01LndNdxJ40RZelczcVZ9uHIfUjx1ww4qdGjgWHQAeKMijHRVqxupVyiF8eoSRExgVMPyY86HRSjarWvevUv-2q1r6hUi_0F8v5p39yNYP8gnnUvge0xAMuv9x6SQuMhGLA-gZmUjf7_9n3-C2cGH7zRwz0cAPs4p7D4VUwhV1Tdrn1Y68DYWgUhxG_V4LzY</recordid><startdate>20121101</startdate><enddate>20121101</enddate><creator>Mokin, Maxim, MD, PhD</creator><creator>Kass-Hout, Tareq, MD</creator><creator>Kass-Hout, Omar, MD</creator><creator>Zivadinov, Robert, MD, PhD</creator><creator>Mehta, Bijal, MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20121101</creationdate><title>Blood Pressure Management and Evolution of Thrombolysis-associated Intracerebral Hemorrhage in Acute Ischemic Stroke</title><author>Mokin, Maxim, MD, PhD ; Kass-Hout, Tareq, MD ; Kass-Hout, Omar, MD ; Zivadinov, Robert, MD, PhD ; Mehta, Bijal, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c525t-c99a6274eff98f8732d4e921b0d6d5b3efe4abed85f6c90ffabb2f5cc344ff723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Acute stroke</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>blood pressure</topic><topic>Blood Pressure - drug effects</topic><topic>Brain Ischemia - drug therapy</topic><topic>Cardiovascular</topic><topic>Cerebral Hemorrhage - chemically induced</topic><topic>Cerebral Hemorrhage - diagnostic imaging</topic><topic>Cerebral Hemorrhage - physiopathology</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Fibrinolytic Agents - administration &amp; dosage</topic><topic>Fibrinolytic Agents - adverse effects</topic><topic>Hematoma - chemically induced</topic><topic>Hematoma - diagnostic imaging</topic><topic>Hematoma - physiopathology</topic><topic>Humans</topic><topic>intracerebral hemorrhage</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neurology</topic><topic>Retrospective Studies</topic><topic>Stroke - drug therapy</topic><topic>Systole</topic><topic>thrombolysis</topic><topic>Thrombolytic Therapy - adverse effects</topic><topic>Time Factors</topic><topic>tissue plasminogen activator</topic><topic>Tissue Plasminogen Activator - administration &amp; dosage</topic><topic>Tissue Plasminogen Activator - adverse effects</topic><topic>Tomography, X-Ray Computed</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mokin, Maxim, MD, PhD</creatorcontrib><creatorcontrib>Kass-Hout, Tareq, MD</creatorcontrib><creatorcontrib>Kass-Hout, Omar, MD</creatorcontrib><creatorcontrib>Zivadinov, Robert, MD, PhD</creatorcontrib><creatorcontrib>Mehta, Bijal, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of stroke and cerebrovascular diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mokin, Maxim, MD, PhD</au><au>Kass-Hout, Tareq, MD</au><au>Kass-Hout, Omar, MD</au><au>Zivadinov, Robert, MD, PhD</au><au>Mehta, Bijal, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Blood Pressure Management and Evolution of Thrombolysis-associated Intracerebral Hemorrhage in Acute Ischemic Stroke</atitle><jtitle>Journal of stroke and cerebrovascular diseases</jtitle><addtitle>J Stroke Cerebrovasc Dis</addtitle><date>2012-11-01</date><risdate>2012</risdate><volume>21</volume><issue>8</issue><spage>852</spage><epage>859</epage><pages>852-859</pages><issn>1052-3057</issn><eissn>1532-8511</eissn><abstract>Background There is limited knowledge on the radiographic features of thrombolysis-induced hemorrhage. The factors that influence early hematoma expansion have not been elucidated. Methods Patients presenting with a symptomatic intracerebral hemorrhage (ICH) as a result of intravenous (IV) thrombolysis with tissue plasminogen activator (tPA) for acute ischemic stroke and had noncontrast computed tomographic (CT) scans of the head were included in this retrospective study. Calculation of hematoma volumes was obtained. Analysis of covariance was used to evaluate for the effect of baseline blood pressure (BP) on initial hematoma volume and further growth. Results Of 267 patients who were treated with intravenous tPA for acute ischemic stroke at our facility between January 1, 2005 and December 31, 2009, 17 patients developed symptomatic ICH and were included in the final analysis. There was a positive correlation between baseline level of systolic BP after thrombolysis and initial hematoma volume (r = 0.46; P = .03) but not for the diastolic BP (r = 0.07; P = .40). There was a significant increase in mean hematoma volume expansion when comparing results between the first and second CT scans (median 9 hours, 22 minutes; 14.9 ± 19.6 cm3 to 26.0 ± 26.7 cm3 ; P = .04). There was also a negative association between the reduction of systolic BP and hematoma growth (r = -0.67; P = .02), but no correlation with change in diastolic BP (r = -0.22; P = .28). Conclusions Once diagnosed, thrombolysis-induced symptomatic ICH undergoes significant early expansion in size. Systolic BP may play a role in hematoma expansion.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>21703878</pmid><doi>10.1016/j.jstrokecerebrovasdis.2011.05.006</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1052-3057
ispartof Journal of stroke and cerebrovascular diseases, 2012-11, Vol.21 (8), p.852-859
issn 1052-3057
1532-8511
language eng
recordid cdi_proquest_miscellaneous_1139617955
source MEDLINE; Elsevier ScienceDirect Journals
subjects Acute stroke
Aged
Aged, 80 and over
Antihypertensive Agents - therapeutic use
blood pressure
Blood Pressure - drug effects
Brain Ischemia - drug therapy
Cardiovascular
Cerebral Hemorrhage - chemically induced
Cerebral Hemorrhage - diagnostic imaging
Cerebral Hemorrhage - physiopathology
Disease Progression
Female
Fibrinolytic Agents - administration & dosage
Fibrinolytic Agents - adverse effects
Hematoma - chemically induced
Hematoma - diagnostic imaging
Hematoma - physiopathology
Humans
intracerebral hemorrhage
Male
Middle Aged
Neurology
Retrospective Studies
Stroke - drug therapy
Systole
thrombolysis
Thrombolytic Therapy - adverse effects
Time Factors
tissue plasminogen activator
Tissue Plasminogen Activator - administration & dosage
Tissue Plasminogen Activator - adverse effects
Tomography, X-Ray Computed
title Blood Pressure Management and Evolution of Thrombolysis-associated Intracerebral Hemorrhage in Acute Ischemic Stroke
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T13%3A18%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Blood%20Pressure%20Management%20and%20Evolution%20of%20Thrombolysis-associated%20Intracerebral%20Hemorrhage%20in%20Acute%20Ischemic%20Stroke&rft.jtitle=Journal%20of%20stroke%20and%20cerebrovascular%20diseases&rft.au=Mokin,%20Maxim,%20MD,%20PhD&rft.date=2012-11-01&rft.volume=21&rft.issue=8&rft.spage=852&rft.epage=859&rft.pages=852-859&rft.issn=1052-3057&rft.eissn=1532-8511&rft_id=info:doi/10.1016/j.jstrokecerebrovasdis.2011.05.006&rft_dat=%3Cproquest_cross%3E1139617955%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1139617955&rft_id=info:pmid/21703878&rft_els_id=1_s2_0_S1052305711001133&rfr_iscdi=true